News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared     11/4/2015
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug     10/23/2015
Gilead (GILD)'s New HIV Drug Genvoya Shows Lower Side-Effects Over Longer Term in Two Late-Stage Studies     10/22/2015
Turing Pharma Not Justified in Increasing Daraprim Price by 5,000 Percent, BioSpace Readers Say     9/25/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In     9/25/2015
Outcry Forces Turing Pharma to Reduce Price Increase of Toxoplasmosis Drug     9/24/2015
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall     7/9/2015
Johnson & Johnson (JNJ) HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400     7/9/2015
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Exciting Time for Biotech in New Jersey     6/29/2015
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS     5/12/2015
Gilead (GILD)'s Next-Gen HIV Drug Heads to the FDA, Stock Soars     4/10/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/3/2015
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV     3/2/2015

News from Around the Web
Charlie Sheen Has HIV. Five Things You Might Not Know About The Virus     11/18/2015
Daily Pills Protect People Against HIV, Whitman-Walker Clinic Study Finds     11/17/2015
Powerful Plastic Microscope Brings Better Diagnostic Care For World's Rural Poor, Rice University Reveals     10/21/2015
Fat-Coated Drugs Keep Immune Cells Free Of HIV, University of Rochester Study     10/20/2015
Science Won't Stop Until It Beats AIDS, Says HIV Pioneer     10/9/2015
Detecting HIV Diagnostic Antibodies With DNA Nanomachines, University Of Montreal Study     10/9/2015
Vaginal Microbes Species Traps HIV, May Be A Biological Condom Someday, University of North Carolina Study     10/8/2015
WHO Ramps Up HIV Drug Push With Call For Early Treatment For All     9/30/2015
Silicone Vaginal Rings To Deliver Antiviral Drugs, Protect Women Against HIV, University Jean Monnet Of Saint-Etienne Study     9/22/2015
International Team Discovers Natural Defense Against HIV, Michigan State University Study     9/16/2015
Encouraging Results From Real-World Users Of Gilead (GILD)'s HIV-Prevention Pill Truvada     9/14/2015
2-Pound DNA-Reader Could Help Fight Ebola, TB, HIV     7/30/2015
Teen's HIV In Remission Despite Stopping Treatment As A Child, Pasteur Institute Reveals     7/21/2015
$4 Million Boost To Turn The Tide On AIDS In Cuyahoga County     7/7/2015
Cuba Becomes First To Eliminate Mother-To-Child HIV     7/1/2015

Press Releases
Sangamo BioSciences (SGMO) Announces Presentation At The 2015 Piper Jaffray Healthcare Conference     11/24/2015
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Single Tablet Regimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide) For The Treatment Of HIV-1 Infection     11/23/2015
GeoVax Labs Inc. (GOVX.OB) To Commemorate World AIDS Day 2015     11/20/2015
Mylan (MYL) Launches Generic Viramune XR Extended-Release Tablets, 100 mg     11/16/2015
Sangamo BioSciences (SGMO) Announces Publication Of Improved Method For Efficient Targeted Integration In Hematopoietic Stem Cells And T-cells     11/9/2015
Advanced Biological Laboratories SA (ABL) Launches HIV And HCV DeepChek SingleRound Genotyping And Sequencing Assays     11/9/2015
Sangamo BioSciences (SGMO) To Present Data From ZFP Therapeutic Programs At Annual Meeting Of The American Society of Hematology     11/6/2015
FDA Approves Gilead (GILD)’s Single Tablet Regimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide) For Treatment Of HIV-1 Infection     11/5/2015
ViiV Healthcare Announces Positive Headline Results From A Study Of Two Drug Injectable Regimen For HIV Maintenance Therapy     11/3/2015
Janssen Sciences Ireland UC Release: First Investigational All Injectable Long Acting HIV Combination Regimen Study Results At 32 Weeks Announced     11/3/2015
Janssen-Cilag International NV (JNJ) Receives Positive CHMP Opinion Recommending EDURANT (rilpivirine) For The Treatment Of Adolescents Aged 12 To <18 Years With HIV-1 Infection     10/26/2015
Bristol-Myers Squibb (BMY) Release: Complete Phase IIa Study Of HIV-1 Investigational Maturation Inhibitor Demonstrates Positive Results For Therapy Designed To Attack Virus Differently Than Existing Treatments     10/23/2015
CytoDyn Injects First Patient In Its Current Phase III Study     10/22/2015
Arno Therapeutics Demonstrates AR-12 Has Potent Antiviral Activity Against Drug-Resistant HIV Strains     10/22/2015
Sangamo BioSciences (SGMO) Announces Third Quarter 2015 Conference Call And Webcast     10/22/2015